MedCrypt, the proactive cybersecurity solution provider for medical device manufacturers, today announced additional funding from Dexcom Ventures, the corporate venture capital arm of Dexcom. This extension follows MedCrypt's Series B funding round in November 2022 with investments from Intuitive Ventures, Johnson & Johnson Innovation - JJDC, Inc. (JJDC), among others, bringing the company's funding to date to $36.4 million.

MedCrypt is a medical device cybersecurity technology provider that uses cryptography to protect data sent to and from medical devices. MedCrypt's security software ensures data delivered to devices comes from a trusted source and provides remote, real-time monitoring to alert vendors of suspicious behaviors that may yield potential security threats to their company, devices and users.